CRIYX Fees and Costs — Columbia Select Corporate Income Fund, Institutional 3 Class
Data updated: 2026-09-28
The net expense ratio is 0.47%: a 0.49% management fee plus 0.02% other expenses, less a 0.04% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $36 in broker commissions, and portfolio turnover was 118%.
CRIYX Fees and Expenses
Annual operating expenses and sales charges of CRIYX. Prospectus, as of April 30, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.49% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.02% |
| Gross expense ratio | 0.51% |
| Fee waiver | −0.04% |
| Net expense ratio | 0.47% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
CRIYX Costs Over Time
On $10,000 invested in CRIYX, assuming 5% a year before costs, total costs come to $297 over 5 years, cutting the return by 0.49% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.47%) | $49 | $155 | $270 |
| Lost growth on money paid in costs | $0 | $8 | $27 |
| Total costs | $49 | $162 | $297 |
| Value after costs | $10,451 | $11,414 | $12,466 |
| Impact on return, per year | 0.49% | 0.49% | 0.49% |
CRIYX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending April 30, 2026.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: $36
- Bought from dealers (principal trades, not a cost): $3.7B
- Portfolio turnover (prospectus): 118%
- Securities lending: none during the year
CRIYX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Goldman Sachs & Co. LLC | $36 | 100.00% |
CRIYX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $425.7M | 14.98% |
| Citadel Securities LLC | $368.6M | 12.98% |
| J.P. Morgan Securities LLC | $366.5M | 12.90% |
| Citigroup Global Markets Inc. | $362.5M | 12.76% |
| Goldman Sachs & Co. LLC | $348.4M | 12.27% |
| BofA Securities, Inc. | $285.5M | 10.05% |
| Deutsche Bank Securities Inc. | $185.0M | 6.51% |
| RBC Capital Markets, LLC | $170.0M | 5.98% |
| Barclays Capital Inc. | $167.9M | 5.91% |
| BNP Paribas Securities Corp. | $160.4M | 5.65% |
Columbia Select Corporate Income Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| CRIYX | Institutional 3 Class | 0.47% | none |
| CPIRX | Institutional 2 Class | 0.50% | none |
| SRIJX | Class S | 0.60% | none |
| SRINX | Institutional Class | 0.60% | none |
| LIIAX | Class A | 0.85% | 4.75% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.